Literature DB >> 10350048

Phosphorylation of rat brain calpastatins by protein kinase C.

M Averna1, R De Tullio, F Salamino, E Melloni, S Pontremoli.   

Abstract

Calpastatin, the natural inhibitor of calpain, is present in rat brain in multiple forms, having different molecular masses, due to the presence of one (low Mr form) or four (high Mr form) repetitive inhibitory domains. Recombinant and native calpastatin forms are substrates of protein kinase C, which phosphorylates a single serine residue at their N-terminus. Furthermore, both low and high Mr calpastatins are phosphorylated by protein kinase C at the same site. These calpastatin forms are phosphorylated also by protein kinase A, although with a lower efficiency. The incorporation of a phosphate group determines an increase in the concentration of Ca2+ required to induce the formation of the calpain-calpastatin complex. This effect results in a large decrease of the inhibitory efficiency of calpastatins. We suggest that phosphorylation of calpastatin represents a mechanism capable to balance the actual amount of active calpastatin to the level of calpain to be activated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10350048     DOI: 10.1016/s0014-5793(99)00461-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Changes in intracellular calpastatin localization are mediated by reversible phosphorylation.

Authors:  M Averna; R de Tullio; M Passalacqua; F Salamino; S Pontremoli; E Melloni
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

2.  Molecular cloning and characterization of caprine calpastatin gene.

Authors:  Dai Hua Wang; Gang Yi Xu; Deng Jun Wu; Cheng Li Zheng
Journal:  Mol Biol Rep       Date:  2010-11-21       Impact factor: 2.316

3.  Cross-talk between calpain and caspase-3 in penumbra and core during focal cerebral ischemia-reperfusion.

Authors:  Ming Sun; Yumei Zhao; Chao Xu
Journal:  Cell Mol Neurobiol       Date:  2007-12-21       Impact factor: 5.046

4.  Characterization of a new p94-like calpain form in human lymphocytes.

Authors:  Roberta De Tullio; Roberto Stifanese; Franca Salamino; Sandro Pontremoli; Edon Melloni
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

5.  Calpain activity is generally elevated during transformation but has oncogene-specific biological functions.

Authors:  N O Carragher; B D Fonseca; M C Frame
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

6.  Quantitative proteomic and phosphoproteomic profiling of ischemic myocardial stunning in swine.

Authors:  Xue Wang; Xiaomeng Shen; Brian R Weil; Rebeccah F Young; John M Canty; Jun Qu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-30       Impact factor: 4.733

7.  Mitofusin 2 Regulates Axonal Transport of Calpastatin to Prevent Neuromuscular Synaptic Elimination in Skeletal Muscles.

Authors:  Luwen Wang; Ju Gao; Jingyi Liu; Sandra L Siedlak; Sandy Torres; Hisashi Fujioka; Mikayla L Huntley; Yinfei Jiang; Haiyan Ji; Tingxiang Yan; Micah Harland; Pichet Termsarasab; Sophia Zeng; Zhen Jiang; Jingjing Liang; George Perry; Charles Hoppel; Cheng Zhang; Hu Li; Xinglong Wang
Journal:  Cell Metab       Date:  2018-07-12       Impact factor: 27.287

8.  p38γ MAPK contributes to left ventricular remodeling after pathologic stress and disinhibits calpain through phosphorylation of calpastatin.

Authors:  Aminah A Loonat; E Denise Martin; Negin Sarafraz-Shekary; Katharina Tilgner; Nicholas T Hertz; Rebecca Levin; Kevan M Shokat; Alma L Burlingame; Pelin Arabacilar; Shahzan Uddin; Max Thomas; Michael S Marber; James E Clark
Journal:  FASEB J       Date:  2019-10-22       Impact factor: 5.834

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.